Patents Assigned to Celgene
  • Substituted acylhydroxamic acids and method of reducing TNFalpha levels
    Publication number: 20040167174
    Abstract: Imido and amido substituted acyihydroxamidic acids which reduce the levels of TNF&agr; and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin -2-yl)-3-(3-ethoxy-4-methoxyphenyl)propandylamino)propanoate.
    Type: Application
    Filed: February 25, 2004
    Publication date: August 26, 2004
    Applicant: Celgene
    Inventors: Hon-Wah Man, George W. Muller, Shaei Y. Huang